Published in Proteomes on March 07, 2016
Metabolic Profiles in Cell Lines Infected with Classical Swine Fever Virus. Front Microbiol (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science (1995) 68.34
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol (2008) 13.49
Evolution of MRSA during hospital transmission and intercontinental spread. Science (2010) 13.34
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis (2002) 11.30
Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science (1994) 10.04
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med (2010) 8.50
Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis (2008) 7.45
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med (2012) 6.36
Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity (2009) 6.24
Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol (2001) 5.57
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 4.48
Staphylococcus aureus: superbug, super genome? Trends Microbiol (2004) 3.53
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest (2010) 3.40
Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol (2006) 3.37
Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog (2010) 3.11
Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog (2009) 3.05
Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med (2004) 2.84
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol (2005) 2.82
Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis (2009) 2.79
Molecular programming of B cell memory. Nat Rev Immunol (2011) 2.73
Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 2.72
Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A (2006) 2.71
Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol (2014) 2.54
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis (2006) 2.52
The immune epitope database (IEDB) 3.0. Nucleic Acids Res (2014) 2.50
Dual RNA-seq unveils noncoding RNA functions in host-pathogen interactions. Nature (2016) 2.35
Dual RNA-seq of pathogen and host. Nat Rev Microbiol (2012) 2.32
DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 2.28
Staphylococcal innate immune evasion. Trends Microbiol (2005) 2.18
Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med (2011) 2.15
Antibody-protein interactions: benchmark datasets and prediction tools evaluation. BMC Struct Biol (2007) 2.14
Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol (2010) 2.14
Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol (2014) 2.10
Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) (2013) 1.99
Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol (2008) 1.97
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
Anaerobic gene expression in Staphylococcus aureus. J Bacteriol (2007) 1.95
Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J Infect Dis (2010) 1.92
Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother (2011) 1.89
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2012) 1.83
Reverse vaccinology, a genome-based approach to vaccine development. Vaccine (2001) 1.82
Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics (2006) 1.79
Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A (2002) 1.75
Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol (2005) 1.73
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J Bacteriol (2002) 1.73
A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. BMC Genomics (2007) 1.73
Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis (2011) 1.72
Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A (2011) 1.70
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol (2005) 1.67
Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun (2010) 1.62
Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis (2009) 1.62
Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J Bacteriol (2006) 1.49
Gene expression microarrays: glimpses of the immunological genome. Nat Immunol (2006) 1.48
Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis (2009) 1.46
Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers. BMC Genomics (2006) 1.45
Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis (2006) 1.45
Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect (2005) 1.45
Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One (2009) 1.41
Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine (2006) 1.37
Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis (2012) 1.36
Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol (2006) 1.34
Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol (2012) 1.33
The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev (2014) 1.32
Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J Infect Dis (2010) 1.30
Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol Med Microbiol (2004) 1.28
Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA carriage, infection and transmission. Nat Commun (2015) 1.27
Nitric oxide stress induces different responses but mediates comparable protein thiol protection in Bacillus subtilis and Staphylococcus aureus. J Bacteriol (2008) 1.27
Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett (2001) 1.27
A proteomic view of an important human pathogen--towards the quantification of the entire Staphylococcus aureus proteome. PLoS One (2009) 1.27
Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics (2002) 1.27
Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation. Proteomics (2010) 1.27
Predicting the virulence of MRSA from its genome sequence. Genome Res (2014) 1.23
The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis. Front Immunol (2013) 1.22
Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol (2014) 1.22
Proteomic analysis of antioxidant strategies of Staphylococcus aureus: diverse responses to different oxidants. Proteomics (2008) 1.21
Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response. Int J Med Microbiol (2009) 1.21
Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis (2006) 1.21
T-cell epitope vaccine design by immunoinformatics. Open Biol (2013) 1.20
Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect (2014) 1.18
Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol (2012) 1.15
Opinion: Interpretation of the complexity of innate immune responses by functional genomics. Nat Rev Immunol (2002) 1.13
Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect (2009) 1.12
Survival of methicillin-resistant Staphylococcus aureus (MRSA) on naturally contaminated dry mops. J Hosp Infect (1996) 1.12
Molecular fingerprinting of Staphylococcus aureus from bone and joint infections. Eur J Clin Microbiol Infect Dis (2010) 1.12
Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis (2010) 1.10
Plasmodium immunomics. Int J Parasitol (2010) 1.09
Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol (2009) 1.09
Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps. PLoS One (2014) 1.09
Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol (2014) 1.08
Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One (2013) 1.08